BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 38660140)

  • 21. Chaperone-mediated autophagy degrades mutant p53.
    Vakifahmetoglu-Norberg H; Kim M; Xia HG; Iwanicki MP; Ofengeim D; Coloff JL; Pan L; Ince TA; Kroemer G; Brugge JS; Yuan J
    Genes Dev; 2013 Aug; 27(15):1718-30. PubMed ID: 23913924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy?
    Choudhury S; Kolukula VK; Preet A; Albanese C; Avantaggiati ML
    Cell Cycle; 2013 Apr; 12(7):1022-9. PubMed ID: 23466706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple stress signals activate mutant p53 in vivo.
    Suh YA; Post SM; Elizondo-Fraire AC; Maccio DR; Jackson JG; El-Naggar AK; Van Pelt C; Terzian T; Lozano G
    Cancer Res; 2011 Dec; 71(23):7168-75. PubMed ID: 21983037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
    Li D; Marchenko ND; Schulz R; Fischer V; Velasco-Hernandez T; Talos F; Moll UM
    Mol Cancer Res; 2011 May; 9(5):577-88. PubMed ID: 21478269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first 30 years of p53: growing ever more complex.
    Levine AJ; Oren M
    Nat Rev Cancer; 2009 Oct; 9(10):749-58. PubMed ID: 19776744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.
    Terzian T; Suh YA; Iwakuma T; Post SM; Neumann M; Lang GA; Van Pelt CS; Lozano G
    Genes Dev; 2008 May; 22(10):1337-44. PubMed ID: 18483220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live or let die: the cell's response to p53.
    Vousden KH; Lu X
    Nat Rev Cancer; 2002 Aug; 2(8):594-604. PubMed ID: 12154352
    [No Abstract]   [Full Text] [Related]  

  • 28. Early stages of p53-induced apoptosis are reversible.
    Geske FJ; Lieberman R; Strange R; Gerschenson LE
    Cell Death Differ; 2001 Feb; 8(2):182-91. PubMed ID: 11313720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
    An WG; Chuman Y; Fojo T; Blagosklonny MV
    Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant p53 in Cancer Progression and Targeted Therapies.
    Zhu G; Pan C; Bei JX; Li B; Liang C; Xu Y; Fu X
    Front Oncol; 2020; 10():595187. PubMed ID: 33240819
    [No Abstract]   [Full Text] [Related]  

  • 31. Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers.
    Martinho MS; Nancarrow DJ; Lawrence TS; Beer DG; Ray D
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):449-464. PubMed ID: 33130332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GOF Mutant p53 in Cancers: A Therapeutic Challenge.
    Dolma L; Muller PAJ
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291874
    [No Abstract]   [Full Text] [Related]  

  • 33. Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications.
    Oduah EI; Sharfstein ST; Seetharamu N; Grossman SR; Litovchick L
    Front Oncol; 2024; 14():1363543. PubMed ID: 38660140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing the vulnerabilities of p53 mutants in lung cancer - Focusing on the proteasome: a new trick for an old foe?
    Oduah EI; Grossman SR
    Cancer Biol Ther; 2020 Apr; 21(4):293-302. PubMed ID: 32041464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting mutant p53 stabilization for cancer therapy.
    Wang J; Liu W; Zhang L; Zhang J
    Front Pharmacol; 2023; 14():1215995. PubMed ID: 37502209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of p53 in regulation of hematopoiesis in health and disease.
    Barajas S; Cai W; Liu Y
    Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.